Medicare Part D enrollment levels out

Insurance benefits

Enrollment in Medicare stand-alone prescription drug plans (PDP) grew 3.8 percent year over year, although that represents a significant drop from the 14.7 percent increase between February 2012 and February 2013, according to newly released findings from Mark Farrah Associates (MFA).

The Medicare Part D market has 62 participating organizations as of February 2014, but six companies control 80 percent of market. UnitedHealthcare, with 22.1 percent of the market, covers the largest number of PDP subscribers--5.1 million people.

Rounding out the top six are CVS Caremark, Humana, Express Scripts, Aetna and Cigna. Each covered more than 1 million PDP members as of last month, according to MFA.

Webinar

How Providers Can Leverage Technology to Accelerate Business Recovery

Join us for this webinar on July 14th at 1pm ET / 10am PT to hear how organizations are responding to the COVID-19 crisis, re-engaging patients with postponed elective services, and utilizing contact tracing to support the health and wellbeing of their communities.

Since Aetna acquired Coventry Health Care, the combined enrollment of PDP subscribers fell 17.5 percent from February 2013. Humana, on the other hand, experienced the largest enrollment boost, adding 580,259 members as of February. The insurer now holds 16 percent of the Medicare Part D market.

"It appears the conversion of employer plans resulted in a onetime spike and now that most have converted to managed care plans, overall enrollment gains for PDP plans has leveled off," Debra A. Donahue, a vice president at MFA, said Wednesday in a statement.

Last fall, Blue Cross Blue Shield of Louisiana exited the Medicare Part D market. The move affected about 13,000 seniors enrolled in the Blue Cross BlueRx prescription plans, which the company offered since 2006.

Meanwhile, earlier this month, the Obama administration dropped proposed changes to Medicare Part D after facing strong opposition. The draft revisions to Medicare C and D regulations intended to fight fraud and save the program about $1.3 billion over five years. However, patient groups, pharmaceutical manufacturers and lawmakers from both parties pushed back against changes, maintaining the program didn't need fixing.

For more:
- check out the report

Suggested Articles

Seema Verma said the COVID-19 pandemic has “exposed a lot of inefficiencies” in the healthcare system—with one of the largest being data.

The Trump administration has proposed an enhanced Medicare add-on payment to encourage greater use of home dialysis for beneficiaries with ESRD.

Infectious disease expert Anthony Fauci said the U.S. is still in the middle of the first wave of COVID-19 and recent spikes are a resurgence.